Skip to content

Validation of Fitbit Measurements in Hospitalized General Medicine Patients

Validation of Fitbit Measurements in Hospitalized General Medicine Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07229833
Enrollment
33
Registered
2025-11-17
Start date
2025-06-01
Completion date
2025-12-31
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Admission to GIM, GIM Diagnosis, Medicine

Keywords

wearable, sleep, heart rate

Brief summary

Patients admitted to the General Internal Medicine ward are sick and in need of monitoring that cannot be provided at home or treatments best administered in hospital. Standard care currently includes vital signs measurements and in some cases ECG. Wearable devices that continuous monitor patients could provided added information to improve the care of inpatients. This could include more monitoring and catching deterioration before it happens. Wearables have been shown to be largely accurate for monitoring heart rate, however it is still necessary to determine if they can reliably measure sleep, activity, and other health metrics. For this, study investigators are evaluating the validity of FitBit Sense 2 (or other FitBit devices) for measurement of sleep, activity, heart rate, respiratory rate, and oxygen saturation.

Interventions

None listed

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subject inclusion criteria. * General internal medicine patients admitted to General Medicine Wards. * Able to consent. * 18 years of age or older Subject

Exclusion criteria

. * Patients who are purely palliative "comfort measures only" where measuring vital signs would not be appropriate and will be excluded. * To reduce the potential risk of transmitting nosocomial infections, patients under contact precautions for methicillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile infections will also be excluded. * This study will also exclude patients at risk of vascular compromise of the arm or leg on which the wearable device was to be placed, such as patients with deep venous thrombosis, dialysis fistulas, and severe upper extremity trauma. * Expected discharge less than 24 hours

Design outcomes

Primary

MeasureTime frameDescription
Fitbit Sense 2 vs. StepWatch for activity (step count)Collected over 24 hours in 1 min binsComparisons of step counts between Fitbit and Modus StepWatch
Fitbit Sense 2 vs. Nox T3 for heart rate (bpm)Fitbit collected over 24 hours in 1 min bins and Nox T3 collected during nighttime sleep in 1 sec binsComparisons of HR between Fitbit and Nox pulse oximeter
Fitbit Sense 2 vs. Nox T3 for respiratory rate (breaths per minute)Fitbit collected over 24 hours in 1 min bins and Nox T3 collected during nighttime sleep in 1 sec bins.Comparisons of RR between Fitbit and Nox RIP (respiratory inductive plethysmograph)
Fitbit Sense 2 vs. Nox T3 for oxygen saturation (SpO2, %)Fitbit collected over 24 hours in 1 min bins and Nox collected during nighttime sleep in 1 sec bins.Comparisons of SpO2 between Fitbit and Nox T3
Fitbit Sense 2 vs. Nox T3 for total sleep time (min)Fitbit and Nox T3 collected during nighttime sleep (1 night)Comparisons of sleep TST between Fitbit and Nox T3
Fitbit Sense 2 vs. Nox T3 for sleep efficiency (%)Fitbit and Nox T3 collected during nighttime sleep (1 night)Comparisons of SE between Fitbit and Nox T3
Fitbit Sense 2 vs. Nox T3 for sleep stages (%, min)Fitbit and Nox T3 collected during nighttime sleep (1 night)Comparisons of sleep stages (NREM - stage 1-3, REM) between Fitbit and Nox T3
Fitbit Sense 2 vs. Nox T3 for wake after sleep onset (min)Fitbit and Nox T3 collected during nighttime sleep (1 night)Comparisons of WASO between Fitbit and Nox T3
Fitbit Sense 2 vs. Nox T3 for time of sleep onset and wake timeFitbit and Nox T3 collected during nighttime sleep (1 night)Comparisons of sleep onset time and wake time between Fitbit and Nox T3

Secondary

MeasureTime frameDescription
Fitbit Sense 2 vs. Sleep Diary for total sleep time (min)Collected during nighttime sleep (1 night)Comparisons of total sleep time between Fitbit and self-reported sleep diary.
Fitbit Sense 2 vs. Sleep Diary for sleep efficiency (%)Collected during nighttime sleep (1 night)Comparisons of sleep efficiency between Fitbit and self-reported sleep diary.
Fitbit Sense 2 vs. Sleep Diary for time of sleep scheduleCollected during nighttime sleep (1 night)Comparisons of time of sleep between Fitbit and self-reported sleep diary.
Fitbit Sense 2 vs. Sleep Diary for wake after sleep onset (min)Collected during nighttime sleep (1 night)Comparisons of WASO between Fitbit and self-reported sleep diary.
Subgroup analysis based on genderCollected at study baselineGender-based subgroup analysis of outcomes
Subgroup analysis based on comorbiditiesCollected at study baselineDescriptive data on participant comorbidities (e.g., presence of mobility limiting conditions, etc; yes/no) or subgroup analysis by comorbidities
Subgroup analysis based on use of walking aidsCollected at study baselineSubgroup analysis by walking aid usage or descriptive data on walking aid use among participants (e.g., yes vs. no)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026